Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Pavilion Capital

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 66
Average round size
info
The average size of a deal this fund participated in
$65M
Portfolio companies 56
Rounds per year 1.38
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.15
Exits 7
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Artificial Intelligence
  • Information Technology
Summary

Pavilion Capital is the famous VC, which was founded in 1974. The venture was found in North America in United States. The leading representative office of defined VC is situated in the New York.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - Taiwan. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Robotics, Genetics. Among the most popular portfolio startups of the fund, we may highlight Orchard Therapeutics, Schrodinger, Insilico Medicine.

We also calculated 1 valuable employee in our database.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Pavilion Capital, startups are often financed by Insignia Ventures Partners, East Ventures, ZhenFund. The meaningful sponsors for the fund in investment in the same round are Insignia Ventures Partners, SMDV, EDBI. In the next rounds fund is usually obtained by Vertex Ventures Southeast Asia & India, Vertex Ventures, Venrock.

The important activity for fund was in 2019. The increased amount of exits for fund were in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. Opposing the other organizations, this Pavilion Capital works on 7 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pavilion Capital:
Typical Co-investors
Pavilion Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pavilion Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

JNPMEDI

Health Care
Medical
$12M22 Nov 2022 South Korea, Gangwon-do, South Korea

Vow

Biotechnology
Food and Beverage
$49M14 Nov 2022 Sydney, New South Wales, Australia

LevitasBio

Analytics
Biotechnology
Health Diagnostics
Therapeutics
$35M24 Oct 2022 San Francisco, California, United States

Asuene

Energy
Local
Renewable Energy
$22M14 Sep 2022 Chiyoda, Japan

Insilico Medicine

Artificial Intelligence
Biotechnology
Genetics
Health Care
Pharmaceutical
$35M10 Aug 2022 Hong Kong Island, Hong Kong, China

Insilico Medicine

Artificial Intelligence
Biotechnology
Genetics
Health Care
Pharmaceutical
$60M06 Jun 2022 Hong Kong Island, Hong Kong, China

MOMA Therapeutics

Biotechnology
Therapeutics
$150M10 May 2022 Cambridge, Massachusetts, United States

RVAC Medicines

Biotechnology
Medical
Product Research
$140M26 Apr 2022 Singapore, Central Region, Singapore

Swatch On

Fashion
$10M22 Apr 2022 South Korea, Gyeonggi-do, South Korea
News
Doctor Anywhere Raises US$65.7M in Series C Financing

– Doctor Anywhere from Singapore develops a tech-led healthcare company.
– The company raised US$65.7M in Series C funding.
– The round was led by Asia Partners and also joined by Novo Holdings A/S, Philips Venture, OSK-SBI Ventures and existing investors Square Peg, EDBI, IHH Healthcare, Kamet Capital and Pavilion Capital.
– The new investment will be used to bolster the company’s market leadership, to further deepen its presence in its existing markets, and to expand into new markets.

Pivot Bio Raises $430M in Series D Funding

– Pivot Bio, a Berkeley, CA-based nitrogen innovator in agriculture, closed a $430m Series D funding.
– The round was led by DCVC and Temasek with participation from Generation Investment Management, G2 Venture Partners, Rockefeller Capital Management, Breakthrough Energy Ventures, Continental Grain Company, Prelude Ventures; Pavilion Capital, Bunge Ventures, Tekfen Ventures, and Roger Underwood.
– The company intends to use the funds to focus on scaling its U.S. business and expanding into key international markets.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pavilion Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: